Effects of the α4β2 Partial Agonist Varenicline on Brain Activity and Working Memory in Abstinent Smokers

Lerman, 2007, Translational research in medication development for nicotine dependence, Nat Rev Drug Discov, 6, 746, 10.1038/nrd2361 Conn, 2008, Opportunities and challenges of psychiatric drug discovery: Roles for scientists in academic, industry, and government settings, Neuropsychopharmacology, 33, 2048, 10.1038/sj.npp.1301638 Hyman, 2003, Medicine, Science, 299, 350, 10.1126/science.1077141 Evans, 2009, Nicotine self-medication of cognitive-attentional processing, Addict Biol, 14, 32, 10.1111/j.1369-1600.2008.00130.x Jacobsen, 2005, Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers, Biol Psychiatry, 57, 56, 10.1016/j.biopsych.2004.10.022 Mendrek, 2006, Working memory in cigarette smokers: Comparison to non-smokers and effects of abstinence, Addict Behav, 31, 833, 10.1016/j.addbeh.2005.06.009 Xu, 2005, Brain activity in cigarette smokers performing a working memory task: Effect of smoking abstinence, Biol Psychiatry, 58, 143, 10.1016/j.biopsych.2005.03.028 Davis, 2005, Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice, J Neurosci, 25, 8708, 10.1523/JNEUROSCI.2853-05.2005 Myers, 2008, Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray, Neuropsychopharmacology, 33, 588, 10.1038/sj.npp.1301425 Hughes, 2007, Measurement of the effects of abstinence from tobacco: A qualitative review, Psychol Addict Behav, 21, 127, 10.1037/0893-164X.21.2.127 Ward, 2001, Self-reported abstinence effects in the first month after smoking cessation, Addict Behav, 26, 311, 10.1016/S0306-4603(00)00107-6 Patterson, 2010, Working memory deficits predict short-term smoking resumption following brief abstinence, Drug Alcohol Depend, 106, 61, 10.1016/j.drugalcdep.2009.07.020 Cosgrove, 2009, Beta2-nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking, Arch Gen Psychiatry, 66, 666, 10.1001/archgenpsychiatry.2009.41 Gotti, 2006, Brain nicotinic acetylcholine receptors: Native subtypes and their relevance, Trends Pharmacol Sci, 27, 482, 10.1016/j.tips.2006.07.004 Sarter, 2009, nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms, Biochem Pharmacol, 78, 658, 10.1016/j.bcp.2009.04.019 Cannady, 2009, Nicotinic antagonist effects in the mediodorsal thalamic nucleus: Regional heterogeneity of nicotinic receptor involvement in cognitive function, Biochem Pharmacol, 78, 788, 10.1016/j.bcp.2009.05.021 Levin, 2006, Nicotinic effects on cognitive function: Behavioral characterization, pharmacological specification, and anatomic localization, Psychopharmacology (Berl), 184, 523, 10.1007/s00213-005-0164-7 Kenney, 2008, Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine, Mol Neurobiol, 38, 101, 10.1007/s12035-008-8037-9 Mansvelder, 2000, Long-term potentiation of excitatory inputs to brain reward areas by nicotine, Neuron, 27, 349, 10.1016/S0896-6273(00)00042-8 Livingstone, 2009, Nicotinic acetylcholine receptors and the ascending dopamine pathways, Biochem Pharmacol, 78, 744, 10.1016/j.bcp.2009.06.004 Brody, 2009, Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette, Neuropsychopharmacology, 34, 282, 10.1038/npp.2008.87 Loughead, 2009, Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype, Mol Psychiatry, 14, 820, 10.1038/mp.2008.132 Rollema, 2007, Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist Varenicline, an effective smoking cessation aid, Neuropharmacology, 52, 985, 10.1016/j.neuropharm.2006.10.016 Mihalak, 2006, Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors, Mol Pharmacol, 70, 801, 10.1124/mol.106.025130 Rollema, 2009, Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition, Biochem Pharmacol, 78, 813, 10.1016/j.bcp.2009.05.033 Raybuck, 2008, Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice, Behav Neurosci, 122, 1166, 10.1037/a0012601 Patterson, 2009, Varenicline improves mood and cognition during smoking abstinence, Biol Psychiatry, 65, 144, 10.1016/j.biopsych.2008.08.028 Owen, 2005, N-back working memory paradigm: A meta-analysis of normative functional neuroimaging studies, Hum Brain Mapp, 25, 46, 10.1002/hbm.20131 McClernon, 2008, Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues, Neuropsychopharmacology, 33, 2148, 10.1038/sj.npp.1301618 Rose, 2007, Regional brain activity correlates of nicotine dependence, Neuropsychopharmacology, 32, 2441, 10.1038/sj.npp.1301379 Azizian, 2008, Severity of nicotine dependence moderates performance on perceptual-motor tests of attention, Nicotine Tob Res, 10, 599, 10.1080/14622200801979159 Heatherton, 1991, The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom Tolerance Questionnaire, Br J Addict, 86, 1119, 10.1111/j.1360-0443.1991.tb01879.x Schnoll, 2009, Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: A validation study, Pharmacol Biochem Behav, 92, 6, 10.1016/j.pbb.2008.10.016 Sheehan, 1998, The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10, J Clin Psychiatry, 59, 22 Lerman, 2004, Individualizing nicotine replacement therapy for the treatment of tobacco dependence: A randomized trial, Ann Intern Med, 140, 426, 10.7326/0003-4819-140-6-200403160-00009 2002, Biochemical verification of tobacco use and cessation, Nicotine Tob Res, 4, 149, 10.1080/14622200210123581 Ragland, 2002, Working memory for complex figures: An fMRI comparison of letter and fractal n-back tasks, Neuropsychology, 16, 370, 10.1037/0894-4105.16.3.370 Zaitsev M, Hennig J, Speck O (2003) Automated onlnie EPI distortion correction for fMRI applications [abstract]. In: Proceedings of the 11th Annual Meeting of the International Society for Magnetic Resonance in Medicine, Toronto, ON, Canada, July 10–16, 2003, 1042. Zeng, 2002, Image distortion correction in EPI: Comparison of field mapping with point spread function mapping, Magn Reson Med, 48, 137, 10.1002/mrm.10200 Woolrich, 2001, Temporal autocorrelation in univariate linear modeling of FMRI data, Neuroimage, 14, 1370, 10.1006/nimg.2001.0931 Worsley, 2001, Statistical analysis of activation images, 251 Ernst, 2001, Effect of nicotine on brain activation during performance of a working memory task, Proc Natl Acad Sci U S A, 98, 4728, 10.1073/pnas.061369098 Beuten, 2006, Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations, Neuropsychopharmacology, 31, 675, 10.1038/sj.npp.1300997 Colilla, 2005, Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women, Pharmacogenet Genomics, 15, 393, 10.1097/01213011-200506000-00004 Smolka, 2006, Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery, Psychopharmacology (Berl), 184, 577, 10.1007/s00213-005-0080-x Yalachkov, 2009, Brain regions related to tool use and action knowledge reflect nicotine dependence, J Neurosci, 29, 4922, 10.1523/JNEUROSCI.4891-08.2009 Goldberg, 2004, Genes and the parsing of cognitive processes, Trends Cogn Sci, 8, 325, 10.1016/j.tics.2004.05.011 Williams, 2006, Under the curve: Critical issues for elucidating D1 receptor function in working memory, Neuroscience, 139, 263, 10.1016/j.neuroscience.2005.09.028 Gentry, 2003, Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors, J Pharmacol Exp Ther, 304, 206, 10.1124/jpet.102.041756 Levin, 2009, Nicotinic alpha7- or beta2-containing receptor knockout: Effects on radial-arm maze learning and long-term nicotine consumption in mice, Behav Brain Res, 196, 207, 10.1016/j.bbr.2008.08.048 Cincotta, 2008, Selective nicotinic acetylcholine receptor agonists: Potential therapies for neuropsychiatric disorders with cognitive dysfunction, Curr Opin Investig Drugs, 9, 47 Poorthuis, 2009, Nicotinic actions on neuronal networks for cognition: General principles and long-term consequences, Biochem Pharmacol, 78, 668, 10.1016/j.bcp.2009.04.031 Livingstone, 2009, Alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex, Eur J Neurosci, 29, 539, 10.1111/j.1460-9568.2009.06613.x Castner, 2004, Animal models of working memory: Insights for targeting cognitive dysfunction in schizophrenia, Psychopharmacology (Berl), 174, 111, 10.1007/s00213-003-1710-9 Savitz, 2006, The molecular genetics of cognition: Dopamine, COMT and BDNF, Genes Brain Behav, 5, 311, 10.1111/j.1601-183X.2005.00163.x Papaleo, 2008, Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice, J Neurosci, 28, 8709, 10.1523/JNEUROSCI.2077-08.2008 Hahn, 2009, Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: An fMRI study, Cereb Cortex, 19, 1990, 10.1093/cercor/bhn226 Thiel, 2007, Visual and auditory alertness: Modality-specific and supramodal neural mechanisms and their modulation by nicotine, J Neurophysiol, 97, 2758, 10.1152/jn.00017.2007 Hahn, 2007, Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network, J Neurosci, 27, 3477, 10.1523/JNEUROSCI.5129-06.2007 Teneggi, 2002, Smokers deprived of cigarettes for 72 h: Effect of nicotine patches on craving and withdrawal, Psychopharmacology (Berl), 164, 177, 10.1007/s00213-002-1176-1 Perkins, 2006, Medication screening for smoking cessation: A proposal for new methodologies, Psychopharmacology (Berl), 184, 628, 10.1007/s00213-005-0105-5 Perkins, 2008, Development of procedures for early screening of smoking cessation medications in humans, Clin Pharmacol Ther, 84, 216, 10.1038/clpt.2008.30 Jacobsen, 2006, C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency, Psychopharmacology (Berl), 188, 530, 10.1007/s00213-006-0469-1 Moss, 2009, Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia, Drug Alcohol Depend, 104, 94, 10.1016/j.drugalcdep.2009.04.005 Van Essen, 2001, An integrated software system for surface-based analyses of cerebral cortex, J Am Med Inform Assoc, 8, 443, 10.1136/jamia.2001.0080443